BUZZ-U.S. STOCKS ON THE MOVE-Valeant Pharma, Tesla, Teva

Mon Jan 4, 2016 7:14am EST
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article | Single Page
[-] Text [+]

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s)

U.S. stock index e-mini futures fell on Monday after weak Chinese economic data reignited fears of a global slowdown, sparking a selloff in stock markets on the first trading day of 2016: Dow Jones industrial average futures were down 1.78 percent at 17,032, S&P 500 futures were down 1.79 percent at 1,999 and Nasdaq 100 futures were down 2.07 percent at 4,492.75.

** VALEANT PHARMACEUTICALS INTERNATIONAL INC, Thursday close $101.65, -4.28 pct premarket

Billionaire investor William Ackman said on Thursday he sold about 5 million shares in the drug company in order to generate a tax loss as investors in his Pershing Square Capital Management face the biggest loss in the company's history.

** TESLA MOTORS INC, Thursday close $240.01, -4.63 pct premarket

The electric car maker said on Sunday that it delivered 17,400 vehicles in the fourth quarter of 2015, just above the low end of its forecast of 17,000-19,000.

Tesla delivered 208 of its new electric SUV, the Model X, in the quarter, below the expectations of some analysts. Robert W Baird analyst Ben Kallo, who had expected Tesla to deliver about 1,000 Model X cars, said deliveries were lower as "the Model X production ramp began later than we had expected" in the fourth quarter.   Continued...